Prenatal risk factors for Tourette Syndrome: a systematic review

BMC Pregnancy and Childbirth

Tamara Pringsheim²  Jing Hu³  Ting-Kuang Chao¹ 

[1] Department of Medicine, University of Alberta, Alberta, Canada;Alberta Children’s Hospital, C4-431, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada;Department of Clinical Neurosciences, University of Calgary, Calgary, Canada

关键词: Risk factors;    Prenatal morbidity;    Tic disorders;    Tourette syndrome;   

Others  :  1128558
DOI  :  10.1186/1471-2393-14-53

 received in 2013-05-23, accepted in 2014-01-14,  发布年份 2014

【 摘 要 】

Background

Tourette Syndrome (TS) appears to be an inherited disorder, although genetic abnormalities have been identified in less than 1% of patients, and the mode of inheritance is uncertain. Many studies have investigated environmental factors that might contribute to the onset and severity of tics and associated comorbidities such as obsessive compulsive disorder (OCD) and attention deficit hyperactive disorder (ADHD). A systematic review and qualitative analysis were performed to provide a broad view of the association between pre- and perinatal factors and TS.

Methods

The Medline, Embase and PsycINFO databases were searched using terms specific to Tourette’s syndrome and keywords such as “pregnancy”, “prenatal”, “perinatal”, “birth” and “neonatal”. Studies were limited to studies on human subjects published in English or French through October 2012.

Results

22 studies were included. Studies were of limited methodological quality, with most samples derived from specialty clinics, and most exposures ascertained retrospectively. The majority of the results for demographic factors of parents, including age, education, socioeconomic status, and marital status, revealed no significant association with the onset of TS, or the presence of comorbidity. Many factors were reported to be significantly associated with the onset of TS, the presence of comorbidity and symptom severity, but the most consistently reported factors were maternal smoking and low birth weight.

Conclusions

There are few studies evaluating the relationship between pre and perinatal events and TS, and existing studies have major limitations, including the use of clinic rather than epidemiologically derived samples, retrospective data collection on pre and perinatal events and multiple hypothesis testing without appropriate statistical correction. The mechanism by which prenatal and perinatal adversities could lead to TS onset or symptom severity is unknown, but may be related to changes in the dopaminergic system as a result of early brain injury.

【 授权许可】

   
2014 Chao et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Bloch M, State M, Pittenger C: Recent advances in Tourette syndrome. Curr Opin Neurol 2011, 24(2):119-25.
• [2]Abelson JF, et al.: Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005, 310(5746):317-20.
• [3]Ercan-Sencicek AG, et al.: L-histidine decarboxylase and Tourette's syndrome. N Engl J Med 2010, 362(20):1901-8.
• [4]Verkerk AJ, et al.: CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 2003, 82(1):1-9.
• [5]Chou IC, et al.: Association of the Slit and Trk-like 1 gene in Taiwanese patients with Tourette syndrome. Pediatr Neurol 2007, 37(6):404-6.
• [6]Deng H, et al.: Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol Scand 2006, 114(6):400-2.
• [7]Fabbrini G, et al.: A large Italian family with Gilles de la Tourette syndrome: clinical study and analysis of the SLITRK1 gene. Mov Disord 2007, 22(15):2229-34.
• [8]Orth M, et al.: Autosomal dominant myoclonus-dystonia and Tourette syndrome in a family without linkage to the SGCE gene. Mov Disord 2007, 22(14):2090-6.
• [9]Zimprich A, et al.: Sequence analysis of the complete SLITRK1 gene in Austrian patients with Tourette's disorder. Psychiatr Genet 2008, 18(6):308-9.
• [10]Alexander GM, Peterson BS: Testing the prenatal hormone hypothesis of tic-related disorders: gender identity and gender role behavior. Dev Psychopathol 2004, 16(2):407-20.
• [11]Burd L, et al.: Prenatal and perinatal risk factors for Tourette disorder. J Perinat Med 1999, 27(4):295-302.
• [12]Csabi G, et al.: Minor physical anomalies in Tourette syndrome. Eur J Psychiatry 2008, 22(3):173-180.
• [13]Khalifa N, Von Knorring AL: Tourette syndrome and other tic disorders in a total population of children: Clinical assessment and background. Acta Paediatr, Int J Paediatr 2005, 94(11):1608-1614.
• [14]Klug MG, et al.: A comparison of the effects of parental risk markers on pre- and perinatal variables in multiple patient cohorts with fetal alcohol syndrome, autism, Tourette syndrome, and sudden infant death syndrome: an enviromic analysis. Neurotoxicol Teratol 2003, 25(6):707-17.
• [15]Kondo K, Nomura Y: Tourette syndrome in Japan: etiologic considerations based on associated factors and familial clustering. Adv Neurol 1982, 35:271-6.
• [16]Leckman JF, et al.: Nongenetic factors in Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1987, 44(1):100.
• [17]Motlagh MG, et al.: Severe psychosocial stress and heavy cigarette smoking during pregnancy: an examination of the pre- and perinatal risk factors associated with ADHD and Tourette syndrome. Eur Child Adolesc Psychiatry 2010, 19(10):755-764.
• [18]Pasamanick B, Kawi A: A study of the association of prenatal and paranatal factors with the development of tics in children; a preliminary investigation. J Pediatr 1956, 48(5):596-601.
• [19]Santangelo SL, et al.: Tourette's syndrome: what are the influences of gender and comorbid obsessive-compulsive disorder? J of the Am Academy of Child & Adolesc Psychiatry 1994, 33(6):795-804.
• [20]Shimada T, et al.: Parental age and assisted reproductive technology in autism spectrum disorders, attention deficit hyperactivity disorder, and Tourette syndrome in a Japanese population. Res Autism Spectrum Disord 2012, 6(1):500-507.
• [21]Pringsheim T, et al.: Prenatal and perinatal morbidity in children with Tourette syndrome and attention-deficit hyperactivity disorder. J Dev Behav Pediatr 2009, 30(2):115-21.
• [22]Iida J, et al.: The clinical features of Tourette's disorder with obsessive-compulsive symptoms. Psychiatry Clin Neurosci 1996, 50(4):185-9.
• [23]Saccomani L, et al.: Tourette syndrome and chronic tics in a sample of children and adolescents. Brain Dev 2005, 27(5):349-52.
• [24]Leckman JF, et al.: Perinatal factors in the expression of Tourette's syndrome: An exploratory study. J Am Acad Child Adolesc Psychiatry 1990, 29(2):220-226.
• [25]Hyde TM, et al.: Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins. Neurology 1992, 42(3 Pt 1):652-8.
• [26]Mathews CA, et al.: Association between maternal smoking and increased symptom severity in Tourette's syndrome. Am J Psychiatr 2006, 163(6):1066-73.
• [27]Bos-Veneman NG, et al.: Role of perinatal adversities on tic severity and symptoms of attention deficit/hyperactivity disorder in children and adolescents with a tic disorder. J Dev Behav Pediatr 2010, 31(2):100-106.
• [28]Bos-Veneman NGP, Minderaa RB, Hoekstra PJ: The DRD4 gene and severity of tics and comorbid symptoms: main effects and interactions with delivery complications. Mov Disord 2010, 25(10):1470-6.
• [29]Atladottir HO, et al.: Variation in incidence of neurodevelopmental disorders with season of birth. Epidemiology 2007, 18(2):240-5.
• [30]Atladottir HO, et al.: Time trends in reported diagnoses of childhood neuropsychiatric disorders: a Danish cohort study. Arch Pediatr Adolesc Med 2007, 161(2):193-8.
• [31]Eapen V, et al.: Clinical features and associated psychopathology in a Tourette syndrome cohort. Acta Neurol Scand 2004, 109(4):255-60.
• [32]Fernandez-Mayoralas DM, et al.: Fetal alcohol syndrome, Tourette syndrome, and hyperactivity in nine adopted children. Pediatr Neurol 2010, 43(2):110-6.
• [33]Griffiths BJ, Hafez A, Stern JS: Month of birth of people attending a tourette syndrome clinic. J Neurol Neurosurg Psychiatry 2010, 81(10):e14.
• [34]Hyde TM, et al.: Electroencephalographic abnormalities in monozygotic twins with Tourette's syndrome. Br J Psychiatry 1994, 164(6):811-817.
• [35]Incagnoli T, Kane R: Developmental perspective of the Gilles de la Tourette syndrome. Percept Mot Skills 1983, 57(3 Pt 2):1271-81.
• [36]Kano Y, Leckman JF, Pauls DL: Clinical characteristics of Tourette syndrome probands and relatives' risk. J Am Acad Child Adolesc Psychiatry 2002, 41(10):1148-1149.
• [37]Micheli F, et al.: Gilles de la Tourette syndrome: Clinical features of 75 cases from Argentina. Behav Neurol 1995, 8(2):75-80.
• [38]Shapiro AK, Shapiro E, Wayne H: Birth, developmental, and family histories and demographic information in Tourette's syndrome. J Nerv Ment Dis 1972, 155(5):335-44.
• [39]Whitaker AH, et al.: Psychiatric outcomes in low-birth-weight children at age 6 years: relation to neonatal cranial ultrasound abnormalities. Arch Gen Psychiatry 1997, 54(9):847-56.
• [40]Zelnik N, et al.: Height distribution in children with Tourette syndrome. J Child Neurol 2002, 17(3):200-4.
• [41]Howson AL, et al.: Clinical and attentional effects of acute nicotine treatment in Tourette's syndrome. Eur Psychiatry 2004, 19(2):102-12.
• [42]Levin ED, et al.: Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) 1996, 123(1):55-63.
• [43]McConville BJ, et al.: The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder. Biol Psychiatry 1992, 31(8):832-40.
• [44]Potter AS, Newhouse PA: Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder. Pharmacol Biochem Behav 2008, 88(4):407-17.
• [45]Silver AA, et al.: Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1996, 35(12):1631-6.
• [46]Silver AA, et al.: Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study. J Clin Psychiatry 2001, 62(9):707-14.
• [47]Fuemmeler BF, Kollins SH, McClernon FJ: Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood. J Pediatr Psychol 2007, 32(10):1203-13.
• [48]Baier CJ, et al.: Gestational restraint stress and the developing dopaminergic system: an overview. Neurotox Res 2012, 22(1):16-32.
• [49]Makkonen I, et al.: Effects of fluoxetine treatment on striatal dopamine transporter binding and cerebrospinal fluid insulin-like growth factor-1 in children with autism. Neuropediatrics 2011, 42(5):207-9.
• [50]Rogers TD, et al.: Reorganization of circuits underlying cerebellar modulation of prefrontal cortical dopamine in mouse models of autism spectrum disorder. Cerebellum 2013, 12(4):547-556.
• [51]Staal WG, de Krom M, de Jonge MV: Brief report: the dopamine-3-receptor gene (DRD3) is associated with specific repetitive behavior in autism spectrum disorder (ASD). J Autism Dev Disord 2012, 42(5):885-8.
• [52]Gardener H, Spiegelman D, Buka SL: Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis. Pediatrics 2011, 128(2):344-55.
• [53]Guinchat V, et al.: Pre-, peri- and neonatal risk factors for autism. Acta Obstet Gynecol Scand 2012, 91(3):287-300.
• [54]Latimer K, et al.: Disruptive behaviour disorders: a systematic review of environmental antenatal and early years risk factors. Child Care Health Dev 2012, 38(5):611-28.